摘要
背景:抗菌素耐药(AMR)对全球公众健康构成严重威胁,需要立即采取行动,最好是长期。目前的药物疗法无法遏制这种威胁,因为微生物能够规避药物的作用机制。从药物发现的角度来看,目前用于抗菌治疗的大多数药物都是小分子。最近的趋势显示使用肽作为候选药物的激增,因为它们比小分子具有显着的优势。 方法:较新的合成策略,如有机金属配合物,肽 - 聚合物结合物,固相,液相和重组DNA技术,鼓励使用肽作为具有许多化学功能的治疗剂,并针对特定应用量身定制。在过去的十年中,许多基于肽的药物已经被食品和药物管理局(FDA)成功地批准。这种成功可归因于它们的高特异性,选择性和功效,对组织的高渗透性,较低的免疫原性和较少的组织积累。考虑到AMR的巨大性,使用抗菌肽(AMPs)可以成为当前治疗策略的可行替代方案。 AMPs天然丰富,可以让合成化学家开发半合成肽分子。 AMP对微生物具有广泛的活性,并且具有绕过微生物的抗性诱导机制的能力。 结果:本综述重点讨论AMPs对各种微生物疾病及其未来前景的潜在应用。还讨论了几个抵制机制及其战略,以突出当前情况下的重要性。 结论:AMP设计,肽合成和生物技术方面的突破已经显示出应对这一挑战的希望,并重新激活了使用AMPs作为抗击AMR的重要武器的兴趣。
关键词: 抗微生物性,抗微生物性,多肽性,发展性,抗性机理,抗攻击性
Current Medicinal Chemistry
Title:Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance
Volume: 24 Issue: 38
关键词: 抗微生物性,抗微生物性,多肽性,发展性,抗性机理,抗攻击性
摘要: Background: Antimicrobial resistance (AMR) has posed a serious threat to global public health and it requires immediate action, preferably long term. Current drug therapies have failed to curb this menace due to the ability of microbes to circumvent the mechanisms through which the drugs act. From the drug discovery point of view, the majority of drugs currently employed for antimicrobial therapy are small molecules. Recent trends reveal a surge in the use of peptides as drug candidates as they offer remarkable advantages over small molecules.
Methods: Newer synthetic strategies like organometalic complexes, Peptide-polymer conjugates, solid phase, liquid phase and recombinant DNA technology encouraging the use of peptides as therapeutic agents with a host of chemical functions, and tailored for specific applications. In the last decade, many peptide based drugs have been successfully approved by the Food and Drug Administration (FDA). This success can be attributed to their high specificity, selectivity and efficacy, high penetrability into the tissues, less immunogenicity and less tissue accumulation. Considering the enormity of AMR, the use of Antimicrobial Peptides (AMPs) can be a viable alternative to current therapeutics strategies. AMPs are naturally abundant allowing synthetic chemists to develop semi-synthetics peptide molecules. AMPs have a broad spectrum of activity towards microbes and they possess the ability to bypass the resistance induction mechanisms of microbes.
Result: The present review focuses on the potential applications of AMPs against various microbial disorders and their future prospects. Several resistance mechanisms and their strategies have also been discussed to highlight the importance in the current scenario.
Conclusion: Breakthroughs in AMP designing, peptide synthesis and biotechnology have shown promise in tackling this challenge and has revived the interest of using AMPs as an important weapon in fighting AMR.
Export Options
About this article
Cite this article as:
Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance, Current Medicinal Chemistry 2017; 24 (38) . https://dx.doi.org/10.2174/0929867324666170815102441
DOI https://dx.doi.org/10.2174/0929867324666170815102441 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
A General Method for the Synthesis of 3,3-bis(indol-3-yl)indolin-2-ones, bis(indol-3-yl)(aryl)methanes and tris(indol-3-yl)methanes Using Naturally Occurring Mandelic Acid as an Efficient Organo-catalyst in Aqueous Ethanol at Room Temperature
Current Green Chemistry Possible Consequences of Blocking Transient Receptor Potential Vanilloid 1
Current Pharmaceutical Biotechnology Immunonutrition in Surgical Patients
Current Drug Targets The Anti-Inflammatory Role of Annexin-1 in Arthritis
Current Rheumatology Reviews Alternative Splicing in Chronic Myeloid Leukemia (CML): A Novel Therapeutic Target?
Current Cancer Drug Targets A Review of IGF1 Signaling and IGF1-related Long Noncoding RNAs in Chemoresistance of Cancer
Current Cancer Drug Targets Peptide-based Radiopharmaceuticals for Targeted Tumor Therapy
Current Medicinal Chemistry Spatiotemporal Regulation of DNA Replication in the Human Genome and its Association with Genomic Instability and Disease
Current Medicinal Chemistry Anti-Tumor Effects of Osthole on Different Malignant Tissues: A Review of Molecular Mechanisms
Anti-Cancer Agents in Medicinal Chemistry Novel Approaches to Cancer Therapy Using Oncolytic Viruses
Current Molecular Medicine Effects of Endocrine Disruptors on Developmental and Reproductive Functions
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Novel Implications for Lysophospholipids, Lysophosphatidic Acid and Sphingosine 1-Phosphate, as Drug Targets in Cancer
Anti-Cancer Agents in Medicinal Chemistry One Hundred Faces of Cyclopamine
Current Pharmaceutical Design EGFR(s) in Aging and Carcinogenesis of the Gastrointestinal Tract
Current Protein & Peptide Science Non-Viral Delivery of RNA Interference Targeting Cancer Cells in Cancer Gene Therapy
Current Gene Therapy Neural Stem Cell Niches in Health and Diseases
Current Pharmaceutical Design Prospects of Bacteriotherapy with Nanotechnology in Nanoparticledrug Conjugation Approach for Cancer Therapy
Current Medicinal Chemistry Atomic Layers in Electrochemical Biosensing Applications - Graphene and Beyond
Current Organic Chemistry Inflammatory Potential of Diet and the Risk of Prostate Cancer: A Casecontrol Study in the West of Iran
Current Nutrition & Food Science Bioluminescent Proteins Prediction with Voting Strategy
Current Bioinformatics